首页 | 本学科首页   官方微博 | 高级检索  
检索        

乳腺癌MMP-2、MMP-9的体外阻断研究
引用本文:李铨,温清泉,廖卫国,漆其光,吴迪,张欣睿,刘志民,刘学奎.乳腺癌MMP-2、MMP-9的体外阻断研究[J].现代肿瘤医学,2014(5):1045-1048.
作者姓名:李铨  温清泉  廖卫国  漆其光  吴迪  张欣睿  刘志民  刘学奎
作者单位:[1]广州医科大学附属肿瘤医院头颈科,广东广州510095 [2]中山大学肿瘤防治中心头颈科华南肿瘤学国家重点实验室,广东广州510060
基金项目:国家自然科学基金青年科学基金项目(编号:81300017);广东省自然科学基金(编号:S2012010010181);广东省自然科学基金博士启动项目(编号:8451018201000858);广州市市属高校科研项目(编号:10A164)
摘    要:目的:探讨乳腺癌MMP-2、MMP-9表达的临床病理联系及直接阻断MMP-2、MMP-9对乳腺癌细胞增殖、侵袭及细胞周期的影响。方法:应用免疫组织化学方法检测48例乳腺癌MMP-2、MMP-9的表达。明胶酶谱法检测乳腺癌MCF-7细胞MMP-2、MMP-9的表达。MCF-7细胞接种于预铺BME的Tran-swell小室上室,与MMP-2、MMP-9的阻断剂CTT共孵育16h,观察阻断MMP-2、MMP-9对MCF-7细胞侵袭能力的影响。MCF-7细胞与CTT共孵育12h后,MTT法检测阻断MMP-2、MMP-9对细胞增殖能力的影响。MCF-7细胞与CTT共孵育24h后,PI染色流式法检测阻断MMP-2、MMP-9对细胞凋亡和细胞周期的影响。结果:48例乳腺癌组织有MMP-2表达者45例(93.75%),MMP-9表达者38例(79.17%),MMP-2和MMP-9在发生淋巴结转移组明显高表达(P<0.05);组织学分级越高,MMP-2和MMP-9的表达越显著(P<0.05)。明胶酶谱法检测:在MCF-7培养上清中检测到MMP-2、MMP-9的表达。在浓度为100μg/ml和200μg/ml时CTT对MCF-7细胞的侵袭抑制率达到39.5%和61.9%。在终浓度为50、100、200μg/ml时,CTT对MCF-7细胞的增殖率均无明显下降(P>0.05)。CTT处理组MCF-7细胞经流式法检测未见凋亡峰,细胞周期各期未见明显阻滞(P>0.05)。结论:MMP-2、MMP-9与乳腺癌的淋巴结转移密切相关,阻断MMP-2、MMP-9可有效抑制乳腺癌的浸润和转移。

关 键 词:乳腺癌  基质金属蛋白酶  免疫组织化学  明胶酶谱  转移

Pectoralis major myocutaneous flap plus in situ skin graft for reconstruction of neck de-fects in irradiated nasopharynx carcinoma patients
Li Quan,Wen Qingquan,Liao Weiguo,Qi Qiguang,Wu Di,Zhang Xinrui,Liu Zhimin,Liu Xuekui.Pectoralis major myocutaneous flap plus in situ skin graft for reconstruction of neck de-fects in irradiated nasopharynx carcinoma patients[J].Journal of Modern Oncology,2014(5):1045-1048.
Authors:Li Quan  Wen Qingquan  Liao Weiguo  Qi Qiguang  Wu Di  Zhang Xinrui  Liu Zhimin  Liu Xuekui
Institution:1 Department of Head and Neck Surgery,Affiliated Tumor Hospital, Guangzhou Medical University, Guangdong Guangzhou 510095, China;2 Department of Head and Neck Surgery, State Key Laboratory of Oncology in South China, Cancer Centre, Sun Yat -Sen University, Guangdong Guangzhou 510060, China)
Abstract:Objective:The Pectoralis major myocutaneous flaP(PMMF)is a commonly used flaP in reconstructive head and neck surgery,but in literature,the flaP is also associated with a high incidence of comPlications due to its large bulk. The aim of the current study was to introduce PMMF Plus in situ skin graft for reconstruction of neck de-fects in irradiated nasoPharynx carcinoma Patients. Methods:From January 2007 to January 2012,8 debulking Proce-dures were Performed on 8 Patients who had received reconstruction with PMMF for defect of the neck. All Patients have recurrent nasoPharynx carcinoma after radical radiotheraPy with clinically PalPable cervical lymPh node metasta-ses and metastatic dePosits involving the neck skin and the underlying soft tissues. The ePidermis and most of the der-mis were harvested from the flaP,regrafted on the defatted flaP and fixed with tie - over dressing for 7 days. Results:The areas of flaP size ranged from 6cm × 9cm to 6cm × 15cm. The average thickness of removed fat was 15. 13mm(n= 8). All the grafted skin and PMMF took well. All Patients were satisfied with aesthetic result of the donor site and the receiving site after surgery. Conclusion:This method can Provide strict thin skin coverage for the neck after PMMF reconstruction to achieve good functional and esthetic requirements.
Keywords:Pectoralis major myocutaneous flap  situ skin graft  neck defects  debulking Procedure  nasopharynx carcinoma
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号